Debilitating Fatigue: By halting the oxidative damage to mitochondrial membranes, S-A-GSH allows the electron transport chain to resume efficient ATP production, helping to lift the heavy, leaden feeling of profound cellular exhaustion
and alleviate inflammation through reduced proinflammatory factors, infiltration of immune cells and downregulated NF-B and JAK/STAT signal pathways
The FDA classified BPC-157 under Category 2 in 2023, citing insufficient human safety data for compounding approval
Compared to oral or injectable forms, cream formulations have less interference with other organs and systems in the body and are safer
Dihexa has not been tested in mood paradigms Conclusion# Dihexa and PE-22-28 both represent genuinely novel approaches to nootropic pharmacology, targeting pathways (HGF/c-Met and TREK-1, respectively) that are largely unexplored in cognitive enhancement research